Member of the Board and Chairman since 2015
Carl Borrebaeck has a DSc in biochemistry with a focus on molecular immunology, and is professor at Lund University. Carl Borrebaeck is a successful entrepreneur who contributed to the start of several new life science companies, including Alligator BioScience AB, BioInvent International AB and Immunovia AB. BioInvent was awarded the prestigious Scrip‘s Licensing Deal of the Year in 2009 and Immunovia received the 2016 “Stars of Innovation Prize”. Carl Borrebaeck received AkzoNobel’s Science Prize in 2009, the Royal Academy of Engineering Science’s gold medal for ground-breaking cancer biomarker research in 2012, Research!Sweden Prize for medical research in 2012 and the BiotechBuilder award in 2017, for outstanding entrepreneurial achievements. Carl Borrebaeck is Director of CREATE Health – the Strategic Centre for Translational Cancer Research, and former Vice President of Lund University, responsible for its innovation system. He is the founding mentor for Nordic Mentor Network for Entrepreneurship (NOME) in Sweden.
Current appointments: Carl Borrebaeck is Chairman of Immunovia AB and CB Ocean Capital AB, board member of Alligator Bioscience AB, Clinical Laserthermia Systems AB, Scandion A/S and partner in Immunova HB.
Previous appointments (last five years): Board member of Atlas Therapeutics AB, BioInvent International AB, LU Holding AB, Medicon Village AB and Wntresearch AB. Deputy board member of Ideon Center AB and Endo Medical AB.